| 产品描述: | GSK3987 is a pan LXRα/β agonist with EC50s of 50 nM, 40 nM for LXRα-SRC1 and LXRβ-SRC1, respectively. GSK3987 increases the expression of ABCA1 and SREBP-1c. GSK3987 induces cellular cholesterol efflux and triglyceride accumulation |
| 靶点: |
EC50: 50 nM (LXRα); 40 nM (LXRβ);LiverXReceptor |
| 体外研究: |
GSK3987 (compound 4) shows activity with EC50s of 0.08 µM, 50 nM, 40 nM for ABCA1, LXRα-SRC1, LXRβ-SRC1, respectively. GSK3987 (30, 100, 300, 1000 nM) increases the expression of ABCA1 and induces cellular cholesterol efflux to apoA1 particles in a dose-dependent manner in primary human macrophages. GSK3987 (6-1500 nM) increases the expression of SREBP-1c and induces triglyceride accumulation in human hepatoma (HepG2) cells in a dose-dependent manner. RT-PCR Cell Line: HepG2 cells Concentration: 6-1500 nM Incubation Time: Result: Increased the expression of SREBP-1c and induced triglyceride accumulation in human hepatoma (HepG2) cells in a dose-dependent manner. |
| 体内研究: |
GSK3987 (化合物 4) 对 ABCA1、LXRα-SRC1、LXRβ-SRC1 的 EC50 活性分别为 0.08 μM、50 nM、40 nM。 GSK3987 (30,100,300,1000 nM) 增加 ABCA1 的表达,并在原代人巨噬细胞中以剂量依赖性方式诱导细胞胆固醇流出至 apoA1 颗粒。 GSK3987 (6-1500 nM) 以剂量依赖性方式增加 SREBP-1c 的表达并诱导甘油三酯在人肝癌 (HepG2) 细胞中的积累。 |
| 参考文献: |
1. Jaye MC, et al. Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure. J Med Chem. 2005 Aug 25;48(17):5419-22. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.601 ml |
13.006 ml |
26.012 ml |
| 5 mM |
0.52 ml |
2.601 ml |
5.202 ml |
| 10 mM |
0.26 ml |
1.301 ml |
2.601 ml |
| 50 mM |
0.052 ml |
0.26 ml |
0.52 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |